Your browser doesn't support javascript.
loading
Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors.
Schramme, Florence; Crosignani, Stefano; Frederix, Kim; Hoffmann, Delia; Pilotte, Luc; Stroobant, Vincent; Preillon, Julie; Driessens, Gregory; Van den Eynde, Benoit J.
Afiliación
  • Schramme F; Ludwig Institute for Cancer Research, Brussels, Belgium.
  • Crosignani S; de Duve Institute, UCLouvain, Brussels, Belgium.
  • Frederix K; iTeos Therapeutics, Gosselies, Belgium.
  • Hoffmann D; iTeos Therapeutics, Gosselies, Belgium.
  • Pilotte L; Ludwig Institute for Cancer Research, Brussels, Belgium.
  • Stroobant V; de Duve Institute, UCLouvain, Brussels, Belgium.
  • Preillon J; Ludwig Institute for Cancer Research, Brussels, Belgium.
  • Driessens G; de Duve Institute, UCLouvain, Brussels, Belgium.
  • Van den Eynde BJ; Ludwig Institute for Cancer Research, Brussels, Belgium.
Cancer Immunol Res ; 8(1): 32-45, 2020 01.
Article en En | MEDLINE | ID: mdl-31806638
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Triptófano Oxigenasa / Neoplasias del Colon / Inhibidores Enzimáticos / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos / Neoplasias Experimentales Idioma: En Revista: Cancer Immunol Res Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Triptófano Oxigenasa / Neoplasias del Colon / Inhibidores Enzimáticos / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos / Neoplasias Experimentales Idioma: En Revista: Cancer Immunol Res Año: 2020 Tipo del documento: Article